Qube Research & Technologies (QRT)
CADL icon

Qube Research & Technologies (QRT)’s Candel Therapeutics CADL Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.94M Buy
+185,617
New +$2.06M ﹤0.01% 2338
2024
Q2 		– Sell
-1
Closed -$2 – 3860
2024
Q1 		$2 Hold
1
– – ﹤0.01% 4364
2023
Q4 		$1 Hold
1
– – ﹤0.01% 4269
2023
Q3 		$1 Buy
+1
New +$1 ﹤0.01% 4033

Other funds holding CADL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Kennedy Capital Management
Kennedy Capital Management St Louis, Missouri $5.31B AUM 40.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Sands Capital Ventures
Sands Capital Ventures Arlington, Virginia $695M AUM 31.12% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CADL Position: Q3 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Candel Therapeutics (CADL) in Q3 2026: 185,617 shares worth $1.94M. The stake represents ﹤0.01% of the portfolio and ranks #2338 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in CADL as recently as Q1 2024.

Qube Research & Technologies (QRT) first reported a position in CADL in Q3 2023 and has held it in 4 quarters since. 106 funds tracked by Wall St. Rank hold CADL as of Q3 2026.

  • Qube Research & Technologies (QRT) held 185,617 shares of Candel Therapeutics worth $1.94M as of Q3 2026.
  • Candel Therapeutics was a new Qube Research & Technologies (QRT) position in Q3 2026.
  • Candel Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #2338 holding.
  • Qube Research & Technologies (QRT) first reported a position in Candel Therapeutics in Q3 2023 and has held it in 4 quarters since.
  • 106 funds tracked by Wall St. Rank held Candel Therapeutics as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.